1/9
Looks like no tags are added yet.

Key terms
health care financing
health care spending
payment models
bundled payments model
capitation model
fee for service model
pay for performance model
Medicare
Medicaid
CHIP (Children's Health Insurance Program)
EMTALA (Emergency Medical Treatment and Labor Act)
Affordable Care Act (ACA)
Health Insurance Marketplace
Single Payer Healthcare
Market Based Reforms
Financing: how health care is paid for (taxes, premiums, employers, etc.)
Spending: how much we spend on health care and how it is distributed
Payment Models: how providers are paid for their services
Payment models and how they affect Care
Fee for Service (FFS) or Volume Based
How: Providers paid per service /visit /procedure
Effects: Incentivizes volume and intensity → more procedures, potential overuse; May weaken preventative care
Capitation/ Per-member-per-month (PmPM)
How: A fixed payment per patient by a health plan, regardless of how much care they need
Effects: Incentivizes cost control and prevention; can promote primary care, but risks under- providing care if not well monitore
Bundled payments/ Episode-based payments
How: Single payment for a defined episode (e.g., joint replacement)
Effects: Encourages coordination across providers, reduces unnecessary variation, and can shift resources to effective peri-operative care and rehab
Value-based/ Pay-for-Performance (P4P)
How: Rewards tied to measured outcomes or quality metrics.
Effects: Directly aligns money with quality goals but depends on good metrics and risk-adjustment to avoid penalizing providers who serve lower income patients
How do the different payment models affect…
How do the different payment models affect resource allocation?
• The model determines where the provider is going to spend their time
• The money source determines what is prioritized
Public dollars → underserved areas
Private dollars → profit opportunities (move it to what makes most money)
How do the different payment models affect access to care?
• Models that promote universal coverage will increase access and health equity
• Models that reward procedure-based care concentrate access around events (hip replacement)
• A fragmented health care system creates delays (authorization) and gaps
How do the different payment models affect health care quality?
• When payments reward volume, quality suffers due to overuse, poor coordination
• When payments reward outcomes, quality and equity of ten improve if metrics are done well
dashboard
• Improving SDOH requires money to be spent on non-medical services
Evolution of US Healthcare Funding
Pre-20th Century
Pay for doctor out of pocket
Public hospitals, almshouses, charity clinics
State hospitals
Minimal federal role
1900s-1930s (pre-WW2)
Great Depression strain
Lack of local funding -> state programs
SSA (1935)
Employers start health insurance 1940s
1950s-1970s
Post War Expansion
Medicare, Medicaid (1965)
Federal funding for hospitals
1980s-1990s
Cost-Containment and Managed Care
Rising costs shift toward managed care
EMTALA (1986) must provide emergency Tx
CHIP (1997) coverage for children
2000s
Growing Uninsured Crisis
Expand Medicaid
Employer Mandate
Health Insurance Marketplaces
2010s: Affordable Care Act (ACA)
Goal: expand coverage, reduce cost, improve quality
Key National-Level Changes:
medicaid Expansion
health Insurance Marketplaces
Individual Mandate (later repealed in 2017)
Employer Mandate
Insurance Reforms: No denial for preexisting conditions, no lifetime caps, coverage for young adults under 26
State-Level Role:
states could run own insurance exchange
Can decide whether to expand medicaid
oversight and regulation of private insurers
Local-level impact:
hospitals saw reduced uncompensate care in states that expanded Medicaid
Local health departments did enrollment outreach and ACA education
Post ACA (2017 to present)
• 2017 Individual Mandate Repealed
• Continued debate over “Medicaid for all” vs. market-based reforms
• State: Some expanded Medicaid af ter initial resistance (via ballot initiatives or legislation).
• Local: health departments increasingly tasked with SDOH, health equity, and community health improvement planning.

Examining the current US Healthcare Delivery System
Where we are now
"not only is the US the only country we studied taht does not have universal health coverage, but its health system can seem designed to discourage people from using services”
“Affordability remains the top reason why some Americans do not sign up for health coverage, while high out-of-pocket costs lead nearly half of working-age adults to skip or delay getting needed care”
The US government spends a higher percentage of its annual GDP on public health cafe than any other country in the world

“Medicaid for all” vs market-based reforms
Market Based Reforms
• Improve private insurance by enhancing competition, consumer choice and market efficiency
Key points
• Change and deregulate private insurance
• Price transparency and market competition to lower prices
• Expand HSAs and Medicare Advantage
Arguments For
• Competition will reduce costs
• More consumer choice/freedom
• Keeps employee sponsored insurance
• Less govt. control
Arguments Against:
• Risks leaving millions uninsured
• Health inequities
• “Profit over patients”
• Hard to navigate for patients
Medicaid for All” (Single-Payer Healthcare)
• Government-run health care system
Key points
• Everyone gets healthcare
• Comprehensive
Arguments For
• Universal coverage for all
• May cut costs by reducing private insurers
• Increases equity
• Likely lowers national healthcare spending in long term
Arguments Against
• Massive tax increases
• Disrupts insurance for 150m
• “Government control”
• Wait times
• Political and logistical hurdles

Healthcare financing and drug costs
• U.S. prescription drug prices were 2.56 times those in 32 comparable countries (Bosworth et al., 2022).
• In 2022, the list prices of several drugs increased by more than $20,000 or 500 percent
Why are costs so high?
cost of R&D
No competition (monopolies)
Life or Death diseases
Pharmaceutical lobbies
How do drug costs affect patient access, affordability, and population health outcomes?
Patient Access
Skip prescriptions
Stuck formularies
Geographic disparities
Affordability
Out of pocket burden
Lack of price transparency
Population Health
Worsening chronic disease
Higher cost burden to Medicare and Medicaid, CHIP
Prevention Types and Costs
Current policy reforms on drug costs
• Government-run drug portal based on Most Favored Nation (MFN) Pricing
• Inflation Reduction Act (IRA)
• Congressional Budget Office (CBO) recommendations
• Stanford Medicine White Paper
Prevention Types and Cost
Primary
cost: low to moderate
Effectiveness: high
Population reach: broad
Lifespan focus: all ages especially children
Secondary
cost: moderate
Effectiveness: moderate to high
Population reach: targeted
Lifespan focus: adults middle and older
Tertiary
cost: high
Effectiveness: moderate
Population reach: individual
Lifespan focus: older adults and chronic patients
